Drug
MMH-407 clinical trials
Also written MMH-407.
Keep track of what changes. Save the MMH-407 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
9 studies that test it; most in 2019 (2)
| Year | Studies |
|---|---|
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 3
- 9
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 0
Studies
Open first, then newest update. How each study uses MMH-407 is read from its arms, and is right about nine times in ten.
Testing it · 9
- Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of Acute Bronchitis in Adult PatientsRecruitingPhase 3Materia Medica HoldingNCT07650227Written as Raphamin
- The Efficacy and Safety of Raphamin in the Treatment of Acute Rhinosinusitis in Adult PatientsRecruitingPhase 3Materia Medica HoldingNCT06901297Written as Raphamin
- Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of ARVI in Children Aged 3-12 YearsRecruitingPhase 3Materia Medica HoldingNCT06715891Written as Raphamin
- Clinical Trial of the Efficacy and Safety of Raphamin in Prevention of Recurrences of Chronic Bacterial CystitisActive, not recruitingPhase 3Materia Medica HoldingNCT06284265Written as Raphamin
- Clinical Trial of the Efficacy and Safety of Raphamin in Combined Treatment of Community-acquired PneumoniaCompletedPhase 3Materia Medica HoldingNCT06263881Written as Raphamin
- Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in OutpatientsCompletedPhase 3Materia Medica HoldingNCT05364671Written as Raphamin
- Clinical Study of Efficacy and Safety of Raphamin in the Treatment of ARVI in Children 12-18 Years OldCompletedPhase 3Materia Medica HoldingNCT04918771Written as Raphamin
- Clinical Trial of Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient AdultsSuspendedPhase 3Materia Medica HoldingNCT04250311Written as MMH-407
- Clinical Trial of Efficacy and Safety of ММН-407 in Acute Respiratory Viral InfectionCompletedPhase 3Materia Medica HoldingNCT04244084Written as MMH-407